Outcomes of patients with unresectable or metastatic melanoma after cessation of immunotherapy following complete response or toxicities

被引：0
|
作者：
Zulkifli, N. S. [1 ]
Tam, L. [1 ]
Mclean, A. [1 ]
Atkinson, V. G. [1 ]
机构：
[1] Princess Alexandra Hosp, Metro South Hlth, Dept Med Oncol, Woolloongabba, Qld, Australia
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2242
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1108P
引用
收藏
页码：S668 / S668
页数：1
相关论文
共 50 条
  • [41] ASO Author Reflections: Mixed Response in Metastatic Melanoma Patients Treated with Immunotherapy
    Daan Jan Willem Rauwerdink
    Genevieve Marie Boland
    Annals of Surgical Oncology, 2020, 27 : 3498 - 3499
  • [42] Specific Patterns of Blood ILCs in Metastatic Melanoma Patients and Their Modulations in Response to Immunotherapy
    Rethacker, Louise
    Roelens, Marie
    Bejar, Claudia
    Maubec, Eve
    Moins-Teisserenc, Helene
    Caignard, Anne
    CANCERS, 2021, 13 (06) : 1 - 14
  • [43] Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma
    Marshall, Julia A.
    Forster, Trevor H.
    Purdie, David M.
    Lanagan, Catherine M.
    O'Connor, Linda E.
    O'Rourke, Michael GE.
    Johnson, Maree K.
    See, Janet L.
    Ellem, Kay AO.
    Martinez, Nathan R.
    Lopez, J. Alejandro.
    Schmidt, Christopher W.
    IMMUNOLOGY AND CELL BIOLOGY, 2006, 84 (03): : 295 - 302
  • [44] Immunotherapy in octogenarian and nonagenarian metastatic melanoma patients
    Cybulska-Stopa, B.
    Zietek, M.
    Czarnecka, A. M. M.
    Piejko, K.
    Galus, L.
    Ziolkowska, B. E.
    Kieszko, S.
    Kempa-Kaminska, N.
    Calik, J.
    Zemelka, T.
    Rolski, J.
    Rogala, P.
    Kubiatowski, T.
    Suwinski, R.
    Mackiewicz, J.
    Rutkowski, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S752 - S753
  • [45] Toxicity management of immunotherapy for patients with metastatic melanoma
    Linardou, Helena
    Gogas, Helen
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (14)
  • [46] A differential response to cetuximab in patients with recurrent unresectable or metastatic head and neck cancer following immunotherapy (10) exposure: An institutional experience.
    Ali, Haythem Y.
    Rahman, Zaid Abdel
    Sheqwara, Jawad
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Complete Response After Stereotactic Body Radiation Therapy With Concurrent Immunotherapy for Vaginal Melanoma
    Schonewolf, Caitlin A.
    Jaworski, Elizabeth M.
    Allen, Steven G.
    McLean, Karen
    Lao, Christopher D.
    Schuchter, Lynn M.
    Tanyi, Janos
    Taunk, Neil K.
    ADVANCES IN RADIATION ONCOLOGY, 2021, 7 (02)
  • [48] Liver metastases and immunotherapy: A barrier to response for metastatic melanoma
    Rubatto, Marco
    Macagno, Nicole
    Pastorin, Ginevra
    Fava, Paolo
    Ceroni, Luca
    Ribero, Simone
    Quaglino, Pietro
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (02) : E186 - E188
  • [49] Association of Antibiotics and Other Drugs with Clinical Outcomes in Metastatic Melanoma Patients Treated with Immunotherapy
    Angrish, Manish D.
    Agha, Arun
    Pezo, Rossanna C.
    JOURNAL OF SKIN CANCER, 2021, 2021
  • [50] Sorafenib continuation or discontinuation in patients with unresectable hepatocellular carcinoma after a complete response
    Zhang, Yingqiang
    Fan, Wenzhe
    Zhu, Kangshun
    Lu, Ligong
    Fu, Sirui
    Huang, Jinhua
    Wang, Yu
    Yang, Jianyong
    Huang, Yonghui
    Yao, Wang
    Li, Jiaping
    ONCOTARGET, 2015, 6 (27) : 24550 - 24559
12345